Atlantis Eyecare offers the most cutting-edge technology and advanced procedures available today. To continue as a leader in the latest eye care methods for patients, we closely work with some of the largest pharmaceutical and medical device organizations in the world. With 9 clinics, our department of research is well-equipped to be involved in a wide range of studies. Each of our renowned ophthalmologists at Atlantis Eyecare have dozens of studies to their names and our research team of certified technicians, optometrists, and coordinators use their vast experience to handle a variety of studies.
Studies we are currently involved in include:
ATLANTIS EYECARE CLINICAL TRIALS
At Atlantis Eyecare we believe that clinical research helps us enrich and develop better treatment options for our patients. In recent years, research has helped us make significant strides in gaining a clearer understanding of eye diseases and how to better treat them.
Without you, improvement in ophthalmic research and care is impossible. The success of our practice's clinical trials depends on your participation. Together, we have the opportunity to gain access to new research treatments not yet available to the public, while helping others by contributing to medical advancements that will help generations to come.
Join our practice and together, our physicians, research personnel, scientists, and range of experts will take the essential steps to develop treatments designed to improve your condition, help advance the existing standard-of-care, and transform ocular therapies for patients all around the world.
LEARN MORE ABOUT OUR CLINICAL TRIALS
If you would like more information about participating in a clinical trial, or to find out if you are a candidate for any of our current studies, please contact us at:
Atlantis Eyecare
ATTN: Samantha Boggs, Clinical Research Manager
7677 Center Avenue, Suite 301
Huntington Beach, CA 92647
Phone: (714) 901-0395
Email: [email protected]
TRAVOPROST INTRAOCULAR IMPLANT CLINICAL STUDY
www.glaukosclinicaltrials.comCLINICAL STUDIES FAQs
What is a clinical study?
Clinical studies are research trials that determine whether a medical treatment or device is safe and effective. Each study focuses on a specific disease and methods of how to better prevent, screen, diagnose, or treat the condition. A clinical study may also test how well medical treatments work and sometimes may evaluate whether the technology used is superior to existing technologies.
Why participate in a clinical study?
Patients typically choose to participate in a clinical study because they may benefit from new treatments or technologies being studied. Patients who participate also benefit from being a part of the future of ophthalmic treatments that may help generations to come.
What is expected of patients who participate in a clinical trial?
Patients are expected to have eye exams and other tests, may need to take medications and/or undergo surgery, and will be asked to return for follow-up examinations which may vary depending on each clinical trial. The follow-up exams will help determine how well the treatment is working.
Is study participant medical information kept confidential?
Patients are identified in clinical studies by study numbers instead of names. Personal information like names or addresses are not disclosed. The medical information thus collected with a study identification number will be available to the study sponsor and government oversight agencies that are involved in the evaluation of investigational devices and procedures.
How long will the clinical study last?
The duration of a clinical study varies and may last a few weeks to a few years. The success of a clinical study often depends on monitoring outcomes over an extended period of time.
What are the benefits of participating in a clinical study?
There may be benefits associated with participating in a clinical study, some include: - Access to a new treatment method that may not otherwise be available to the public - Highest quality of care from experts who closely monitor a patient's medical condition during the study and may continue care after study is completed - New knowledge surrounding the studied disease state or technology that may help others
What are the risks involved in a clinical study?
It's important to remember that whether or not a new treatment will work cannot be determined ahead of time. There is always a chance a new treatment may not work better than an existing treatment, may not work at all, or may be harmful. Some clinical study treatments may also cause side effects; some serious enough to require medical attention. Talk to your doctor for more information on the possible side effects involved with a particular clinical study.
Will my insurance cover costs related to being involved in a clinical trial or will I need to cover any costs?
Patients will not be charged for study-related visits before and after surgery. Patients typically have no out-of-pocket expenses for the study device or the study procedure. Patients and their insurance company may be billed in the usual manner for the costs of medications; health insurance may or may not pay for these charges.
Before agreeing to be in a clinical study, if there are costs associated with the study, patients should contact their healthcare payer/insurer to see if their plan will cover these costs.
How is a patient's safety protected while participating in a clinical trial?
Before a clinical trial begins, researchers must obtain approval from the Institutional Review Board (IRB), whose responsibility it is to protect a patient's care and rights. During the clinical trial, doctors will closely monitor a patient's treatment to see how it's working and if any side effects occur.
What are a patient's rights in a clinical trial?
As a participant in a clinical study, patients have the right to: - Be informed about the study information and purpose - Be informed about the medications or devices used in the study - Have patient responsibilities thoroughly explained before and during the study - Have possible benefits, risks, dangers, and discomforts thoroughly explained before and during the study - Be informed of the benefits and drawbacks of alternative drugs or devices before and during the study - Be informed of medical treatment options should patients need medical attention due to a direct result of the clinical study - Have the opportunity to ask questions regarding the clinical study - Stop involvement with the clinical study at any time without affecting treatment in the future - Be given sufficient time to decide whether to participate in the study without feeling pressured - Maintain privacy by not having a participant's name printed on the study - For studies involving different treatment groups, be informed of the treatment assignment once the study is complete - Be given a signed copy of their consent form
Can participants in clinical studies choose to quit the clinical study if they choose to?
Potential risks, benefits, study duration and time considerations of being involved in clinical trials will be discussed with patients in advance and should be considered when choosing to enroll in a clinical study. Ultimately, some patients are not able to fulfill the commitments of being involved in a clinical study and may choose to leave the clinical study.
Glaucoma and Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension.
Diabetes
Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy (DRCR.net)
Short-term Evaluation of Combination Corticosteroid + Anti-VEGF Treatment for Persistent Central-Involved Diabetic Macular Edema Following Anti-VEGF Therapy (DRCR.net).
Intravitreous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk (DRCR.net).
Macular Degeneration
Multiple Clinical Trials in Advanced Next-Generation Treatments for Wet Macular Degeneration.
Cataracts
AMO Tecnis Toric Post-Approval Study (a research study to evaluate a post-marketed intraocular lens (IOL) for patients with cataracts).
We are also involved in studies for the latest in dry eye therapy and many new advanced technology IOLs and surgical devices.
Drs. Ehsan Sadri, Dwayne K. Logan, and Hani Salehi-Had have achieved a level of excellence in the field of research that few can match.
For more information, please contact our research team at 714-901-0395 or at [email protected].
The Blepharitis Study
A clinical research study for adults with Blepharitis.
Dr Hani Salehi-Had interview at the American Society of Retina Specialists
Safety of Anti-VEGF for Proliferative Diabetic Retinopathy
In this interview from ASRS 2019, Dr. Hani Salehi-Had discusses the safety of anti-VEGF therapy for proliferative diabetic retinopathy. The pooled analysis of 5 DRCR Retina Network studies�protocols I, J, N, S and T�included more than 800 patients; nearly half of the cohort had received anti-VEGF. Overall, investigators found that there was no increased risk of tractional retinal detachment or need for vitrectomy with treatment. This study is important, explains Dr. Salehi-Had, because it supports the safety of anti-VEGF for PDR in a large patient population.
Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy from ASRS on Vimeo.
